Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway

Authors

Kenneth C. Loh, Children's Hospital Oakland, Oakland, CA
Weng-In Leong, Children's Hospital Oakland, Oakland, CA
Morgan E. Carlson, Children's Hospital Oakland, Oakland, CA
Babak Oskouian, Children's Hospital Oakland, Oakland, CA
Ashok Kumar, Children's Hospital Oakland, Oakland, CA
Henrik Fyrst, Children's Hospital Oakland, Oakland, CA
Meng Zhang, Children's Hospital Oakland, Oakland, CA
Richard L. Proia, National Institutes of Health
Eric P. Hoffman, George Washington UniversityFollow
Julie D. Saba, Children's Hospital Oakland, Oakland, CA

Document Type

Journal Article

Publication Date

5-14-2012

Journal

PLoS ONE

Volume

Volume 7, Issue 5

Inclusive Pages

Article number e97218

Keywords

Lysophospholipids--pharmacology; Muscular Dystrophy; Duchenne--drug therapy; Muscular Dystrophy; Duchenne--metabolism; Receptors; Lysosphingolipid--metabolism; STAT3 Transcription Factor--metabolism; Satellite Cells; Skeletal Muscle--drug effects; Satellite Cells; Skeletal Muscle--metabolism; Sphingosine--analogts & derivatives

Comments

Reproduced with permission of PLoS ONE.

Creative Commons License

The person who associated a work with this deed has dedicated the work to the public domain by waiving all of his or her rights to the work worldwide under copyright law, including all related and neighboring rights, to the extent allowed by law.

APA Citation

Loh, K.C., Leong, W., Carlson, M.E., Oskouian, B., Kumar, A., Fyrst, H., Zhang, M., Proia, R.L., Hoffman, E.P., Saba, J.D. (2012). Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway. PLoS ONE, 7(5):e97218.

Peer Reviewed

1

Open Access

1